D. E. Shaw & Co., Inc. Veru Inc. Transaction History

D. E. Shaw & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.17 $88,429 - $154,421	131,984 New	131,984 $95,000
Q4 2022 Feb 14, 2023	SELL	$4.78 - $15.01 $283,807 - $891,203	-59,374 Reduced 85.32%	10,217 $53,000
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $103,549 - $240,128	10,132 Added 17.04%	69,591 $802,000
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $131,674 - $479,779	30,270 Added 103.7%	59,459 $672,000
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $320,083 - $450,930	-70,348 Reduced 70.68%	29,189 $141,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $985,255 - $1.63 Million	-167,276 Reduced 62.69%	99,537 $586,000
Q3 2021 Nov 15, 2021	BUY	$6.78 - $9.89 $1.27 Million - $1.85 Million	186,935 Added 234.03%	266,813 $2.28 Million
Q2 2021 Aug 16, 2021	SELL	$7.24 - $11.2 $2.38 Million - $3.69 Million	-329,203 Reduced 80.47%	79,878 $644,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $3.29 Million - $8.5 Million	409,081 New	409,081 $4.41 Million

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $53.7M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.